Filing Details
- Accession Number:
- 0001578563-19-000037
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-11 16:15:55
- Reporting Period:
- 2019-12-10
- Accepted Time:
- 2019-12-11 16:15:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1534120 | Cerecor Inc. | CERC | Pharmaceutical Preparations (2834) | 450705648 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1746282 | Pericles Calias | C/O Cerecor Inc. 540 Gaither Road, Suite 400 Rockville MD 20850 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-12-10 | 2,913 | $2.85 | 52,462 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | $4.26 | 2028-07-16 | 80,000 | 80,000 | Direct | |
Common Stock | Stock Option (Right to Buy) | $6.22 | 2029-04-01 | 175,000 | 175,000 | Direct | |
Common Stock | Stock Option (Right to Buy) | $4.98 | 2029-05-24 | 25,000 | 25,000 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2028-07-16 | 80,000 | 80,000 | Direct |
2029-04-01 | 175,000 | 175,000 | Direct |
2029-05-24 | 25,000 | 25,000 | Direct |
Footnotes
- These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan.
- One-fourth of the shares subject to the stock option will vest on the first anniversary of the date of grant, and the remaining three-fourths of the shares subject to the stock option will vest in equal monthly installments over the following 36 months.
- One-fourth of the shares subject to the stock option will vest on July 16, 2019, and the remaining three-fourths of the shares subject to the stock option will vest in substantially equal monthly installments over the following 36 months, provided the Reporting Person is then still providing continuous service as an employee, director or consultant.